Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

talazoparib × Other hematologic neoplasm × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3 Genitourinary 3 Gastrointestinal 2 Breast 2 Tumor-Agnostic 1 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 CNS 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

venetoclax 72 Specimen Handling 58 Cytarabine 48 Biopsy 43 Cyclophosphamide 40 Azacitidine 39 fludarabine 29 Rituximab 25 Magnetic Resonance Spectroscopy 21 ibrutinib 20 Vincristine 18 Injections 18 Prednisone 17 Doxorubicin 17 Decitabine 17 blinatumomab 16 Granulocyte Colony-Stimulating Factor 16 Dexamethasone 16 obinutuzumab 15 Methotrexate 15 fludarabine phosphate 14 Daunorubicin 14 decitabine and cedazuridine drug combination 12 acalabrutinib 11 Idarubicin 11 prednylidene 10 merphos 10 deltacortene 10 Whole-Body Irradiation 10 Tacrolimus 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05101551 2026-04-22

PARPAML

Stanford University

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡